- Amended Termination of Registration of a Class of Security under Section 12(b) (15-12B/A)
01 Juni 2012 - 7:00PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15/A
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
001-34604
ONE BIO, CORP.
(Exact name of registrant as specified in its charter)
19950 W Country Club Drive, Suite 100, Aventura, Florida 33180, (305) 328-8662
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.001 per share
(Titles of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
þ
|
|
Rule 12g-4(a)(2)
|
£
|
|
Rule 12h-3(b)(1)(i)
|
£
|
|
Rule 12h-3(b)(1)(ii)
|
£
|
|
Rule 15d-6
|
£
|
Approximate number of holders of record as of the certification or notice date:
281
One Bio, Corp. hereby withdraws its Form 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934, filed on April 20, 2012.
Pursuant to the requirements of the Securities Exchange Act of 1934 One Bio, Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
Date: June 1, 2012
|
By:
|
/s/ Marius Silvasan
|
|
|
Name:
|
Marius Silvasan
|
|
Title:
|
Chief Executive Officer and Director
|
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
One Bio (CE) (USOTC:ONBI)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
Echtzeit-Nachrichten über One Bio Corp (CE) (OTCMarkets): 0 Nachrichtenartikel
Weitere One Bio Corp (PL) News-Artikel